[The role of cancer registries in the evaluation of breast cancer screening].
Cancer registries are necessary to evaluate the efficacy of cancer screening programmes. They provide early indicators of screening efficacy, needed to correct certain campaign failings without waiting for the mortality data, available only 7 to 10 years after the beginning of the screening. They allow to mesure the screening effect not only on the screened women, but also on the entire target population. They also allow to mesure the negative and deleterious effects of the screening. Finally, they are essential to all cost/efficacy study. The evaluation of the breast cancer screening programme in the French department of Bas-Rhin by the cancer Registry showed very quickly the interest of the mesures concerning the quality assurance programme and to estimate on the first screen results basis, that it will be difficult to reduce the mortality by breast cancer to 25%.
Schaffer
P
P
Faculté de Médecine, Laboratoire d'Epidémiologie et de Santé Publique, Strasbourg.
Renaud
R
R
Gairard
B
B
Guldenfels
C
C
D000368:Aged; D001943:Breast Neoplasms / Q000401:mortality / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D005260:Female; D005602:France / Q000453:epidemiology; D006801:Humans; D008403:Mass Screening / Q000592:standards*; D008875:Middle Aged; D011159:Population Surveillance; D015397:Program Evaluation / Q000379:methods; D011785:Quality Assurance, Health Care; D012042:Registries